1. Home
  2. FRO vs TFX Comparison

FRO vs TFX Comparison

Compare FRO & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frontline Plc

FRO

Frontline Plc

HOLD

Current Price

$29.37

Market Cap

4.8B

ML Signal

HOLD

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$108.42

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRO
TFX
Founded
1985
1943
Country
Cyprus
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FRO
TFX
Price
$29.37
$108.42
Analyst Decision
Strong Buy
Hold
Analyst Count
3
10
Target Price
$30.33
$137.11
AVG Volume (30 Days)
3.2M
1.2M
Earning Date
02-27-2026
02-26-2026
Dividend Yield
6.36%
1.28%
EPS Growth
N/A
N/A
EPS
0.98
N/A
Revenue
$1,766,241,000.00
$3,189,988,000.00
Revenue This Year
N/A
$9.60
Revenue Next Year
$19.16
$10.36
P/E Ratio
$28.65
N/A
Revenue Growth
N/A
5.42
52 Week Low
$12.40
$100.18
52 Week High
$29.04
$180.58

Technical Indicators

Market Signals
Indicator
FRO
TFX
Relative Strength Index (RSI) 67.16 43.95
Support Level $27.60 $101.65
Resistance Level $29.04 $107.16
Average True Range (ATR) 0.79 2.76
MACD 0.06 0.73
Stochastic Oscillator 82.00 82.10

Price Performance

Historical Comparison
FRO
TFX

About FRO Frontline Plc

Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Share on Social Networks: